These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33532770)

  • 21. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
    King RG; Silva-Sanchez A; Peel JN; Botta D; Dickson AM; Pinto AK; Meza-Perez S; Allie SR; Schultz MD; Liu M; Bradley JE; Qiu S; Yang G; Zhou F; Zumaquero E; Simpler TS; Mousseau B; Killian JT; Dean B; Shang Q; Tipper JL; Risley CA; Harrod KS; Feng T; Lee Y; Shiberu B; Krishnan V; Peguillet I; Zhang J; Green TJ; Randall TD; Suschak JJ; Georges B; Brien JD; Lund FE; Roberts MS
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.
    Ohtsuka J; Imai M; Fukumura M; Maeda M; Eguchi A; Ono R; Maemura T; Ito M; Yamayoshi S; Kataoka Y; Kawaoka Y; Nosaka T
    iScience; 2021 Dec; 24(12):103379. PubMed ID: 34805782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
    Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
    Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine.
    Sayedahmed EE; Araújo MV; Silva-Pereira TT; Chothe SK; Elkashif A; Alhashimi M; Wang WC; Santos AP; Nair MS; Gontu A; Nissly R; Francisco de Souza Filho A; Tavares MS; Ayupe MC; Salgado CL; Donizetti de Oliveira Candido É; Leal Oliveira DB; Durigon EL; Heinemann MB; Morais da Fonseca D; Jagannath C; Sá Guimarães AM; Kuchipudi SV; Mittal SK
    Mol Ther Methods Clin Dev; 2023 Sep; 30():194-207. PubMed ID: 37502665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
    Lassaunière R; Polacek C; Gram GJ; Frische A; Tingstedt JL; Krüger M; Dorner BG; Cook A; Brown R; Orekov T; Putmon-Taylor T; Campbell TA; Greenhouse J; Pessaint L; Andersen H; Lewis MG; Fomsgaard A
    NPJ Vaccines; 2021 Dec; 6(1):156. PubMed ID: 34930909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaques.
    Buchholz U; Kaiser J; Nelson C; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Ahlers L; Herbert R; Moore I; Wilder-Kofie T; Moore R; Walker A; Lijuan Y; Munir S; Teng IT; Kwong P; Dowdell K; Nguyen H; Kim J; Cohen J; Johnson RF; Garza N; Via L; Barber D; LE Nouen C
    Res Sq; 2023 Sep; ():. PubMed ID: 37790295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates.
    Chiuppesi F; Nguyen VH; Park Y; Contreras H; Karpinski V; Faircloth K; Nguyen J; Kha M; Johnson D; Martinez J; Iniguez A; Zhou Q; Kaltcheva T; Frankel P; Kar S; Sharma A; Andersen H; Lewis MG; Shostak Y; Wussow F; Diamond DJ
    NPJ Vaccines; 2022 Jan; 7(1):7. PubMed ID: 35064109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates.
    Ma Q; Li R; Guo J; Li M; Ma L; Dai J; Shi Y; Dai J; Huang Y; Dai C; Pan W; Zhong H; Zhang H; Wen J; Zhao H; Wu L; Yang W; Zhang B; Yang Z
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and Protective Efficacy of a Single Intranasal Dose Vectored Vaccine Based on Sendai Virus (Moscow Strain) against SARS-CoV-2 Variant of Concern.
    Kochneva GV; Kudrov GA; Zainutdinov SS; Shulgina IS; Shipovalov AV; Zaykovskaya AV; Borgoyakova MB; Starostina EV; Bodnev SA; Sivolobova GF; Grazhdantseva AA; Ivkina DI; Zadorozhny AM; Karpenko LI; P'yankov OV
    Vaccines (Basel); 2024 Jul; 12(7):. PubMed ID: 39066421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Dinnon KH; Leist SR; Baric RS; Barouch DH
    bioRxiv; 2021 Jun; ():. PubMed ID: 34159335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters.
    Jia Q; Bielefeldt-Ohmann H; Maison R; Masleša-Galić S; Bowen R; Horwitz MA
    bioRxiv; 2020 Nov; ():. PubMed ID: 33236013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2.
    Ilinykh PA; Periasamy S; Huang K; Kuzmina NA; Ramanathan P; Meyer MN; Mire CE; Kuzmin IV; Bharaj P; Endsley JR; Chikina M; Sealfon SC; Widen SG; Endsley MA; Bukreyev A
    NPJ Vaccines; 2022 Apr; 7(1):47. PubMed ID: 35468973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.
    Jearanaiwitayakul T; Seesen M; Chawengkirttikul R; Limthongkul J; Apichirapokey S; Sapsutthipas S; Phumiamorn S; Sunintaboon P; Ubol S
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine.
    An D; Li K; Rowe DK; Diaz MCH; Griffin EF; Beavis AC; Johnson SK; Padykula I; Jones CA; Briggs K; Li G; Lin Y; Huang J; Mousa J; Brindley M; Sakamoto K; Meyerholz DK; McCray PB; Tompkins SM; He B
    Sci Adv; 2021 Jul; 7(27):. PubMed ID: 34215591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.
    Rohaim MA; Munir M
    Vaccines (Basel); 2020 Aug; 8(3):. PubMed ID: 32846910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques.
    Harris PE; Brasel T; Massey C; Herst CV; Burkholz S; Lloyd P; Blankenberg T; Bey TM; Carback R; Hodge T; Ciotlos S; Wang L; Comer JE; Rubsamen RM
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34070152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.
    Warner BM; Yates JGE; Vendramelli R; Truong T; Meilleur C; Chan L; Leacy A; Pham PH; Pei Y; Susta L; Wootton SK; Kobasa D
    NPJ Vaccines; 2024 May; 9(1):90. PubMed ID: 38782986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
    Kang YF; Sun C; Zhuang Z; Yuan RY; Zheng Q; Li JP; Zhou PP; Chen XC; Liu Z; Zhang X; Yu XH; Kong XW; Zhu QY; Zhong Q; Xu M; Zhong NS; Zeng YX; Feng GK; Ke C; Zhao JC; Zeng MS
    ACS Nano; 2021 Feb; 15(2):2738-2752. PubMed ID: 33464829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine.
    Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
    bioRxiv; 2021 Jan; ():. PubMed ID: 33501447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.